This article first appeared in Forum, The Edge Malaysia Weekly on November 18, 2024 - November 24, 2024
On April 4, the Ministry of Health (MoH) implemented the Guideline on Natural Products with Modern Claim, bolstering the regulatory framework for natural products in the country. This initiative is poised to stimulate growth in the natural products industry, leveraging Malaysia’s rich biodiversity and fostering ethnopharmacology research. Ethnopharmacology, the scientific study of traditional medicinal practices, offers a promising avenue for drug discovery, combining ancient wisdom with modern research.
Throughout history, nature has been a source of healing. Ethnopharmacology bridges traditional knowledge of medicinal plants with modern medicine, facilitating the transition from traditional remedies to contemporary drug development. Advancements in isolation, characterisation, computational power and cheminformatics have contributed significantly to this progress. This exploration of nature’s untapped potential makes ethnopharmacology an exciting field for future researchers.
Empowering the next generation of researchers, particularly those from biodiversity-rich regions, through ethnopharmacology can foster a diverse skill set for scientific careers providing opportunities to explore the intersection of cultural knowledge and pharmaceutical potential. By harnessing these skills, researchers can bridge the gap between traditional practices and modern scientific methodologies.
Ethnopharmacology research integrates knowledge from five key disciplines: (i) compound extraction; (ii) chromatography analysis; (iii) chromatography analysis in silico studies; (iv) experimentation models; (v) and proof of concept. Researchers engaged in ethnopharmacology gain a broad spectrum of specialised knowledge, emphasising the importance of multidisciplinary approaches in this field and equipping them with expertise across various domains essential for advancing pharmaceutical science and developing effective therapies.
For instance, ethnopharmacological studies bridge traditional knowledge and modern science by identifying and extracting bioactive compounds from natural sources using extraction techniques to isolate potentially therapeutic molecules. Moreover, ethnopharmacology bridges the gap by applying modern tools such as chromatography, which is a powerful tool for isolating and analysing complex mixtures, identifying the specific bioactive molecules responsible for therapeutic effects, paving the way for drug development.
While traditional laboratory techniques are essential, ethnopharmacology research also uses computational tools such as virtual screening, molecular docking and pharmacophore modelling to discover and understand drug candidates, identifying potential risks early on prior to investigating the drug candidates in in vitro biological experimental models. Moving on, the final stage focuses on translating research findings into potential drug therapies through pharmacology and drug development. This involves proof-of-concept studies, pharmacological assays and toxicity assessments, leading to drug prototypes for human clinical trials and fostering translational research exposure.
Beyond the discovery of novel therapeutic agents, ethnopharmacology can also contribute to human well-being by promoting cultural diversity and preserving traditional knowledge. By recognising and valuing traditional medicinal practices, ethnopharmacology helps to maintain cultural heritage and identity. Furthermore, it can foster collaboration between scientists, healthcare providers and indigenous communities, leading to more equitable and inclusive healthcare systems.
Additionally, ethnopharmacology can contribute to sustainable development by promoting the use of natural resources in a responsible and ethical manner. Protecting biodiversity and promoting ecological sustainability are essential for the long-term success of ethnopharmacology. By identifying and conserving medicinal plants and other natural resources, ethnopharmacology can contribute to these goals.
To address the business challenges associated with developing ethnopharmacology while ensuring the protection of biodiversity and promoting sustainability, several strategies can be implemented. One approach is to establish partnerships between academic institutions, pharmaceutical companies and indigenous communities to facilitate knowledge sharing and resource mobilisation. These partnerships can help to address the intellectual property rights issues and reduce the financial burden of research and development.
Another strategy is to invest in research and development infrastructure, including laboratories, equipment and skilled personnel. By providing adequate resources, it is possible to accelerate the pace of ethnopharmaceutical research and development. Additionally, it is essential to establish clear regulatory frameworks and quality control standards to ensure the safety and efficacy of ethnopharmaceutical products. International collaboration can also be beneficial in harmonising regulatory requirements and facilitating the global market access for ethnopharmaceutical products.
In conclusion, ethnopharmacology offers a unique opportunity for the next generation of researchers to transcend traditional scientific exploration. By integrating traditional knowledge with modern science, young researchers can unlock the hidden potential of natural resources and their own potential as future leaders. This multidisciplinary approach fosters a holistic approach to human health and well-being, contributing to the discovery of novel therapeutic agents, preservation of cultural heritage and promotion of sustainable development. While the field faces challenges, such as intellectual property rights and high research costs, addressing these issues through partnerships, investment, and harmonisation of regulatory frameworks can unlock the full potential of ethnopharmacology. Ethnopharmacology research serves as a beacon, illuminating a clear path for researchers to make meaningful contributions to pharmaceutical science and enrich the lives of countless individuals.
Dr Tan Ee Wern is a post-doctoral research fellow at the Sunway Biofunctional Molecules Discovery Centre, Sunway University. Dr Low Ley Hian is head of business development at CRMY Technologies Sdn Bhd, Cancer Research Malaysia. Prof Atanas G Atanasov is the principal investigator at the Medical University of Vienna, Austria and the Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Poland. Prof Goh Bey Hing is the head of the Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University, and the Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Australia.
Save by subscribing to us for your print and/or digital copy.
P/S: The Edge is also available on Apple's App Store and Android's Google Play.